Kidney transplantation outcomes in African-, Hispanic- and Caucasian-Americans with lupus

Lupus

Volumn 21, Issue 1, 2012, Pages 3-12

  Contreras, G ^a   Mattiazzi, A ^a   Schultz, D R ^a   Guerra, G ^a   Ladino, M ^a   Ortega, L M ^a   Garcia Estrada, M ^a   Ramadugu, P ^a   Gupta, C ^a   Kupin, W L ^a   Roth, D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

kidney transplantation; race and ethnicity; subacute lupus erythematosus

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD COMPATIBILITY; CYTOMEGALOVIRUS; DELAYED GRAFT FUNCTION; DONOR; EUROPEAN AMERICAN; FEMALE; GENE LOCUS; GROUPS BY AGE; HISPANIC; HLA SYSTEM; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SURGICAL MORTALITY;

ADULT; AFRICAN AMERICANS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISPANIC AMERICANS; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 83655192312     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311421208     Document Type: Article

References (40)

1. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006 ; 15: 308-318 (Pubitemid 43828810)
2. Alarcón GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998 ; 41: 1173-1180 (Pubitemid 28313417)
3. Alarcón GS, McGwin G, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum. 2001 ; 45: 191-202 (Pubitemid 32954446)
4. Alarcón GS, McGwin G, Roseman JM, et al. Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. Arthritis Rheum. 2004 ; 51: 609-615 (Pubitemid 39056250)
5. Arbuckle MR, James JA, Dennis GJ, et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus. 2003 ; 12: 99-106 (Pubitemid 36240842)
6. Bastian HM, Roseman JM, McGwin G, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002 ; 11: 152-160 (Pubitemid 34296930)
7. Alarcon GS, McGwin G, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus. 2002 ; 11: 95-101 (Pubitemid 34259439)
8. Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford). 2006 ; 45: 1144-1147 (Pubitemid 44542106)
9. Contreras G, Lenz O, Pardo V, et al. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int. 2006 ; 69: 1846-1851 (Pubitemid 43739214)
10. Korbet SM, Schwartz MM, Evans J, Lewis EJ. Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol. 2007 ; 18: 244-254 (Pubitemid 46070148)
11. Barr RG, Seliger S, Appel GB, et al. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant. 2003 ; 18: 2039-2046 (Pubitemid 37220309)
12. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Kidney Int. 1997 ; 51: 1188-1195 (Pubitemid 27186545)
13. Austin HA, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant. 1995 ; 10: 1620-1628
14. Isenberg D, Appel GB, Contreras G, et al. Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology (Oxford). 2010 ; 49: 128-140
15. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of lupus nephritis: a study based on the WHO classification. Am J Med. 1987 ; 83: 877-885
16. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999 ; 341: 1725-1730
17. Bunnapradist S, Chung P, Peng A, et al. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation. 2006 ; 82: 612-618 (Pubitemid 44395229)
18. Ounissi M, Abderrahim E, Hedri H, et al. Kidney transplantation during autoimmune diseases. Transplant Proc. 2009 ; 41: 2781-2783
19. Moroni G, Tantardini F, Gallelli B, et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis. 2005 ; 45: 903-911 (Pubitemid 43181050)
20. Ghafari A, Etemadi J, Ardalan MR. Renal transplantation in patients with lupus nephritis: a single-center experience. Transplant Proc. 2008 ; 40: 143-144 (Pubitemid 351186680)
21. Ward MM. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis. Am J Kidney Dis. 2000 ; 36: 516-525
22. Chelamcharla M, Javaid B, Baird BC, Goldfarb-Rumyantzev AS. The outcome of renal transplantation among systemic lupus erythematosus patients. Nephrol Dial Transplant. 2007 ; 22: 3623-3630 (Pubitemid 350212497)
23. Tang H, Chelamcharla M, Baird BC, Shihab FS, Koford JK, Goldfarb-Rumyantzev AS. Factors affecting kidney-transplant outcome in recipients with lupus nephritis. Clin Transplant. 2008 ; 22: 263-272 (Pubitemid 351689656)
24. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S, Cho YW, Yuge J. Risk rate and long-term kidney transplant survival. Clin Transplant. 1996 ;: 443-458
25. Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant. 2004 ; 4: 438-443 (Pubitemid 38282302)
26. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med. 2001 ; 344: 726-731 (Pubitemid 32204990)
27. Van Dorp WT, van Wieringen PA, Marselis-Jonges E, et al. Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation. 1993 ; 55: 1367-1371 (Pubitemid 23183253)
28. De Koster HS, Anderson DE, Termitjelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules. J Exp Med. 1989 ; 169: 1191-1196 (Pubitemid 19085850)
29. Liu Z, Sun Y, Xi Y, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med. 1993 ; 177: 1643-1650 (Pubitemid 23146131)
30. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet. 1966 ; 2: 662-665
31. Williams GM, Hume DM, Hudson RP, Morris PJ, Kano K, Milgrom F. Hyperacute renal-homograft rejection in man. N Engl J Med. 1968 ; 279: 611-618
32. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004 ; 364: 1814-1827 (Pubitemid 39488068)
33. Reinke P, Fietze E, Ode-Hakim S, et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet. 1994 ; 344: 1737-1738
34. Contreras G, Mattiazzi A, Guerra G, et al. Recurrence of lupus nephritis following kidney transplantation. J Am Soc Nephrol. 2010 ; 21: 1200-1207
35. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003 ; 3: 178-185 (Pubitemid 36323115)
36. Opelz G, Dohler B. Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005 ; 5: 2725-2731
37. Siminoff LA, Arnold RM, Caplan AL, Virnig BA, Seltzer DL. Public policy governing organ and tissue procurement in the United States. Results from the National Organ and Tissue Procurement Study. Ann Intern Med. 1995 ; 123: 10-17
38. Trollinger J, Flores J, Corkill JK, Light JA. Increasing living kidney donation in African Americans. Transplant Proc. 1997 ; 29: 3748-3750 (Pubitemid 28008674)
39. Kamoun M, Israni AK, Joffe MM, et al. Assessment of differences in HLA-A, -B, and -DRB1 allele mismatches among African-American and non-African-American recipients of deceased kidney transplants. Transplant Proc. 2007 ; 39: 55-63 (Pubitemid 46175931)
40. Minniefield WJ, Yang J, Muti P. Differences in attitudes toward organ donation among African Americans and whites in the United States. J Natl Med Assoc. 2001 ; 93: 372-379 (Pubitemid 33614748)